BCRX - Biocryst Pharmaceuticals Inc Revenue Breakdown

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: AMPH ANIP PTCT SUPN HROW

| Held by: VTI XBI IWM VB VXF VBK IBB IWO CALF VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	9.72%	Shs Outstand	254.01M	Perf Week	-5.40%
Market Cap	2.21B	Forward P/E	25.08	EPS next Y	0.35	Insider Trans	-1.65%	Shs Float	229.40M	Perf Month	-12.10%
Enterprise Value	2.83B	PEG	-	EPS next Q	0.13	Inst Own	82.29%	Short Float	16.80%	Perf Quarter	36.27%
Income	-457.98M	P/S	2.49	EPS this Y	-292.05%	Inst Trans	4.12%	Short Ratio	7.42	Perf Half Y	21.25%
Sales	885.72M	P/B	-	EPS next Y	114.92%	ROA	-96.92%	Short Interest	38.53M	Perf YTD	11.46%
Book/sh	-2.18	P/C	9.24	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -23.13%	Perf Year	-12.36%
Cash/sh	0.94	P/FCF	7.54	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 44.90%	Perf 3Y	2.40%
Dividend Est.	-	EV/EBITDA	8.89	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	5.96% 4.50%	Perf 5Y	-33.74%
Dividend TTM	-	EV/Sales	3.19	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.44	Perf 10Y	206.12%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	42.22	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	-4.34%	Beta	0.58	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-4.77%	Rel Volume	0.65	Prev Close	8.90
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	10.24%	Avg Volume	5.19M	Price	8.69
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	2,667,144	Change	-2.32%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)